BiotechTube
Home/Opal Therapeutics/Morgan Stanton
MS

Morgan Stanton

CEO

Opal Therapeutics

Therapeutic Areas

Women's HealthGynecologyOncologyImmunology

Opal Therapeutics Pipeline

DrugIndicationPhase
Uterine Organoid PlatformFibroids, Endometriosis, Gynecological DisordersDiscovery/Pre-clinical